BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 30640752)

  • 1. Myeloid Cell Nuclear Differentiation Antigen (MNDA) Positivity in Primary Follicles: Potential Pitfall in the Differential Diagnosis With Marginal Zone Lymphoma.
    Manohar V; Peerani R; Tan B; Gratzinger D; Natkunam Y
    Appl Immunohistochem Mol Morphol; 2020; 28(5):384-388. PubMed ID: 30640752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myeloid cell nuclear differentiation antigen is expressed in a subset of marginal zone lymphomas and is useful in the differential diagnosis with follicular lymphoma.
    Metcalf RA; Monabati A; Vyas M; Roncador G; Gualco G; Bacchi CE; Younes SF; Natkunam Y; Freud AG
    Hum Pathol; 2014 Aug; 45(8):1730-6. PubMed ID: 24925224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IRTA1 and MNDA Expression in Marginal Zone Lymphoma: Utility in Differential Diagnosis and Implications for Classification.
    Wang Z; Cook JR
    Am J Clin Pathol; 2019 Feb; 151(3):337-343. PubMed ID: 30346478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study of the Utility of Myeloid Cell Nuclear Differentiation Antigen (MNDA) in the Diagnosis of Marginal Zone Lymphoma.
    Gupta N; Roychoudry S; Sticco KL; Hsu P; Zhang X; Sheikh-Fayyaz S
    Appl Immunohistochem Mol Morphol; 2023 Apr; 31(4):217-223. PubMed ID: 36867739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MNDA expression and its value in differential diagnosis of B-cell non-Hodgkin lymphomas: a comprehensive analysis of a large series of 1293 cases.
    Zhang LF; Zhang Y; Shui RH; Lu HF; Jiang WH; Cai X; Li XQ; Yu BH
    Diagn Pathol; 2024 Apr; 19(1):60. PubMed ID: 38627702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of MNDA as a new marker for nodal marginal zone lymphoma.
    Kanellis G; Roncador G; Arribas A; Mollejo M; Montes-Moreno S; Maestre L; Campos-Martin Y; Ríos Gonzalez JL; Martinez-Torrecuadrada JL; Sanchez-Verde L; Pajares R; Cigudosa JC; Martin MC; Piris MA
    Leukemia; 2009 Oct; 23(10):1847-57. PubMed ID: 19474799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relevance of Additional Immunohistochemical Markers in the Differential Diagnosis of Small B-Cell Lymphomas: A Case-Control Study.
    Kıvrak H; Yüksel S; Ateş C; Merter M; Kaygusuz G; Özcan M; Kuzu I
    Turk J Haematol; 2022 Aug; 39(3):178-187. PubMed ID: 34619856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myeloid nuclear differentiation antigen: an aid in differentiating lymphoplasmacytic lymphoma and splenic marginal zone lymphoma in bone marrow biopsies at presentation.
    Righi S; Novero D; Godio L; Bertuzzi C; Bacci F; Agostinelli C; Sagramoso C; Rossi M; Piccioli M; Gazzola A; Mannu C; Roncador G; Sabattini E
    Hum Pathol; 2022 Jun; 124():67-75. PubMed ID: 35339566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical Expression of Lymphoid Enhancer Binding Factor 1 in CD5-Positive Marginal Zone, Lymphoplasmacytic, and Follicular Lymphomas.
    Patel N; Durkin L; Bodo J; Hsi ED
    Am J Clin Pathol; 2020 Apr; 153(5):646-655. PubMed ID: 31953940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cutaneous b-cell lymphomas of follicular and marginal zone types: use of Bcl-6, CD10, Bcl-2, and CD21 in differential diagnosis and classification.
    de Leval L; Harris NL; Longtine J; Ferry JA; Duncan LM
    Am J Surg Pathol; 2001 Jun; 25(6):732-41. PubMed ID: 11395550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myeloid Cell Nuclear Differentiation Antigen (MNDA) Expression Distinguishes Extramedullary Presentations of Myeloid Leukemia From Blastic Plasmacytoid Dendritic Cell Neoplasm.
    Johnson RC; Kim J; Natkunam Y; Sundram U; Freud AG; Gammon B; Cascio MJ
    Am J Surg Pathol; 2016 Apr; 40(4):502-9. PubMed ID: 26796502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic value of STMN1, LMO2, HGAL, AID expression and 1p36 chromosomal abnormalities in primary cutaneous B cell lymphomas.
    Verdanet E; Dereure O; René C; Tempier A; Benammar-Hafidi A; Gallo M; Frouin E; Durand L; Gazagne I; Costes-Martineau V; Cacheux V; Szablewski V
    Histopathology; 2017 Oct; 71(4):648-660. PubMed ID: 28594133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunocytochemical analysis of MNDA in tissue sections and sorted normal bone marrow cells documents expression only in maturing normal and neoplastic myelomonocytic cells and a subset of normal and neoplastic B lymphocytes.
    Miranda RN; Briggs RC; Shults K; Kinney MC; Jensen RA; Cousar JB
    Hum Pathol; 1999 Sep; 30(9):1040-9. PubMed ID: 10492038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunohistochemical patterns of follicular dendritic cell meshwork and Ki-67 in small B-cell lymphomas].
    Shi YF; Li XH
    Zhonghua Bing Li Xue Za Zhi; 2013 Apr; 42(4):222-6. PubMed ID: 23928527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of germinal center cell markers by extranodal marginal zone lymphomas of MALT type within colonized follicles, a diagnostic pitfall with follicular lymphoma.
    Poveda J; Cassidy DP; Zhou Y; Alderuccio JP; Lossos IS; Vega F; Chapman J
    Leuk Lymphoma; 2021 May; 62(5):1116-1122. PubMed ID: 33283568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrent mutations in genes involved in nuclear factor-κB signalling in nodal marginal zone lymphoma-diagnostic and therapeutic implications.
    van den Brand M; Rijntjes J; Hebeda KM; Menting L; Bregitha CV; Stevens WB; van der Velden WJ; Tops BB; van Krieken JH; Groenen PJ
    Histopathology; 2017 Jan; 70(2):174-184. PubMed ID: 27297871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical analysis of the novel marginal zone B-cell marker IRTA1 in malignant lymphoma.
    Ikeda JI; Kohara M; Tsuruta Y; Nojima S; Tahara S; Ohshima K; Kurashige M; Wada N; Morii E
    Hum Pathol; 2017 Jan; 59():70-79. PubMed ID: 27666766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of C4d deposition in the follicular lymphoma and MALT lymphoma and their relationship with follicular dendritic cells.
    Bu X; Zheng Z; Wang C; Yu Y
    Pathol Res Pract; 2007; 203(3):163-7. PubMed ID: 17307308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MNDA binds NPM/B23 and the NPM-MLF1 chimera generated by the t(3;5) associated with myelodysplastic syndrome and acute myeloid leukemia.
    Xie J; Briggs JA; Morris SW; Olson MO; Kinney MC; Briggs RC
    Exp Hematol; 1997 Oct; 25(11):1111-7. PubMed ID: 9328447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Abnormal expression of bcl-10 protein in extranodal marginal zone B cell lymphoma of mucosa-associated lymphoid tissue lymphoma type].
    Li BZ; Zhou XY; Ye HT; Yang WT; Fan YZ; Lu HF; Shi DR
    Zhonghua Bing Li Xue Za Zhi; 2007 Dec; 36(12):819-24. PubMed ID: 18346354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.